Acute coronary syndrome (ACS) was associated with lower inner vessel length density, measured via optical coherence tomography angiography (OCT-A), and with higher concentrations of angiopoietin-2 and osteoprotegerin, according to study results published in Scientific Reports.
Acute coronary syndrome (ACS) was associated with lower inner vessel length density, measured via optical coherence tomography angiography (OCT-A), and with higher concentrations of angiopoietin-2 and osteoprotegerin, according to study results published in Scientific Reports.
Cardiovascular risk factors like hypertension and diabetes lead to systemic inflammation and vascular stress, which in turn contribute to microvascular impairment and coronary macro and microvascular alterations. These alterations are closely associated, and together contribute to the pathophysiology of myocardial ischemia, researchers explained.
Because of these associations, the assessment of myocardial microvascularization is of major interest, so as to estimate a patient’s risk of acute coronary events. However, only invasive procedures are currently available.
In order to reinforce previous analyses of systemic microvascularization through biomarkers of angiogenesis and inflammation, researchers compared retinal microvascularization with OCT-A and systemic microvascularization biomarkers in patients with a high cardiovascular risk profile and controls.
A total of 62 eyes from patients with ACS who presented to cardiac intensive care units and 42 eyes of control patients from an ophthalmology department were included in the study. Thirty individuals in the high cardiovascular risk group exhibited hypertension (48%), 8 had diabetes (13%) and 24 were obese (39%). Researchers collected data from blood samples for each group and carried out OCT-A imaging on each patient.
Analyses revealed:
In addition, researchers found age was significantly correlated with inner vessel length density and inner perfusion density. Overall, the results strengthen the hypothesis "that retinal vasculature status does not act independently and can reflect a systemic cardiovascular alteration.”
Patients with the most severe ACS who were unable to have a retinal examination were excluded from the study. This may have introduced selection bias, marking a limitation to the study. Future studies should also to take into account axial length in order to correct for magnification error.
“OCT-A could be a useful parameter to consider together with other pre-existing cardiovascular risk factors to assess high cardiovascular risk profiles and improve the screening of these patients in primary prevention,” authors concluded.
Reference
Hannappe M, Arnould L, Méloux A, et al. Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. Sci Rep. Published online October 7, 2020. doi:10.1038/s41598-020-73861-z
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More
PAH Therapies Improve Outcomes in PH-ILD
March 26th 2025Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among individuals who have idiopathic pulmonary fibrosis. Overall, most cases of PH in the setting of ILD are mild.
Read More